Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation (vol 71, pg 237, 2011)

被引：0
|
作者：
Atar, D. [1 ]
Banach, M. [2 ]
Ehrlich, J. R. [3 ]
Fedida, D. [4 ,5 ]
Lip, G. Y. H. [6 ]
Savelieva, I. [7 ]
机构：
[1] Univ Oslo, Div Cardiol, Oslo, Norway
[2] Med Univ Lodz, Dept Hypertens, Lodz, Poland
[3] Goethe Univ Frankfurt, Div Cardiol, Frankfurt, Germany
[4] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada
[5] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada
[6] Univ Birmingham, Ctr Cardiovasc Sci, Birmingham, W Midlands, England
[7] St Georges Univ London, Div Cardiac & Vasc Sci, London, England
来源：
DRUGS | 2011年 / 71卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：381 / 381
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Intravenous Vernakalant in Rapid Cardioversion of Recent Onset Atrial Fibrillation
    Hoteit, Abbas
    Nahlawi, Acile
    Moumneh, Mohammad Bahij
    Hebbo, Elsa
    Abdulhai, Farah
    Saleh, Bernard Abi
    Khoury, Maurice
    Refaat, Marwan
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2023, 34 : S55 - S56
  • [32] Intravenous amiodarone in treatment of recent-onset atrial fibrillation - Reply
    Galve, E
    Rius, T
    Ballester, R
    Sagrista, J
    GarciaDelCastillo, H
    GarciaDorado, D
    SolerSoler, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (04) : 1081 - 1082
  • [33] Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation A protocol for systematic review and meta-analysis
    Li, Hong
    Liang, Yi
    Song, Xuejing
    Liu-Huo, Wu-Sha
    Chen, Wen
    Tang, Chao
    Zhao, Lizhi
    Bai, Xue
    MEDICINE, 2022, 101 (10) : E29038
  • [34] Emergency Department Management of Recent-Onset Atrial Fibrillation
    Weant, Kyle A.
    Matuskowitz, Andrew J.
    Gregory, Haili
    Caporossi, Jeffrey
    Hall, Gregory A.
    ADVANCED EMERGENCY NURSING JOURNAL, 2020, 42 (03) : 176 - 185
  • [35] Vernakalant Use in Cardioversion of Recent Onset Atrial Fibrillation: A Case Report
    Nikovic, Vuk
    Blagojevic, Predrag
    Milenkovic, Dusan
    Laggner, Anton
    Domanovits, Hans
    Bulajic, Ranka
    ACTA FACULTATIS MEDICAE NAISSENSIS, 2018, 35 (03) : 256 - 261
  • [36] Systematic Review and Meta-analysis Appraising Efficacy and Safety of Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation
    Ma, Wenfang
    Guo, Xiying
    Wang, Qixian
    Sun, Guihu
    Wang, Jie
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 76 (01) : 32 - 41
  • [37] Intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation: systematic review and meta-analysis
    Guerra, Federico
    Matassini, Maria Vittoria
    Scappini, Lorena
    Urbinati, Alessia
    Capucci, Alessandro
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (09) : 1067 - 1075
  • [38] Vernakalant Hydrochloride: A Novel Atrial-selective Agent for the Cardioversion of Recent-onset Atrial Fibrillation in the Emergency Department
    Stiell, Ian G.
    Dickinson, Garth
    Butterfield, Noam N.
    Clement, Catherine M.
    Perry, Jeffrey J.
    Vaillancourt, Christian
    Calder, Lisa A.
    ACADEMIC EMERGENCY MEDICINE, 2010, 17 (11) : 1175 - 1182
  • [39] Pharmacological conversion of recent-onset atrial fibrillation: A systematic review
    Heldal, Magnus
    Atar, Dan
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2013, 47 (01) : 2 - 10
  • [40] Vernakalant Shows Superiority to Ibutilide in Recent-onset Atrial Fibrillation: A Randomized Controlled Trial at the Emergency Department
    Simon, Alexander
    Niederdockl, Jan
    Skyllouriotis, Ekaterini
    Schutz, Nikola
    Weiser, Christoph
    Herkner, Harald
    Laggner, Anton N.
    Domanovits, Hans
    Spiel, Alexander
    CIRCULATION, 2015, 132
12345